Overcoming Tagraxofusp-Erzs Monotherapy Resistance in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in a Real-World Clinical Setting

Overview of attention for article published in Journal of Immunotherapy and Precision Oncology, August 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter: 7 X users

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 16 X posts from 7 X users, with an upper bound of 24,491 followers.

RT @JIPOEditors: Case report by Dhakal et al. explores the treatment of blastic plasmacytoid dendritic cell neoplasm #BPDCN with TAG as wel…

Case report by Dhakal et al. explores the treatment of blastic plasmacytoid dendritic cell neoplasm #BPDCN with TAG as well as resistance to the treament and alternative options https://t.co/lmmyxn6h3X #tagraxofusp #JIPO @OncologyNetwork https://t.co/G3…

RT @JIPOEditors: Recent case report by Dhakal et al. explores the treatment of blastic plasmacytoid dendritic cell neoplasm #BPDCN with TAG…

Recent case report by Dhakal et al. explores the treatment of blastic plasmacytoid dendritic cell neoplasm #BPDCN with TAG as well as resistance to the treament and alternative options https://t.co/lmmyxn6h3X #tagraxofusp #JIPO @OncologyNetwork https://…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 12 additional X posts.